【市場調査レポート】カスタム配合療法のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Custom Compounded Therapy Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。カスタム配合療法のグローバル市場インサイト・予測（～2028年） / Global Custom Compounded Therapy Market Insights, Forecast to 2028 / QY2207C3481資料のイメージです。

• レポートコード：QY2207C3481
• 出版社/出版日：QYResearch / 2022年7月11日
• レポート形態：英文、PDF、114ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界のカスタム配合療法の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にカスタム配合療法の世界市場のxxx％を占める「カスタマイズ薬物」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国のカスタム配合療法の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのカスタム配合療法市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのカスタム配合療法市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

カスタム配合療法のグローバル主要メーカーには、Fagron、Specialist Pharmacy、Nova Laboratories、Athenex Pharma Solutions、ImprimisRx、Fresenius Kabi、Baxter、B. Braun、Galenic Laboratories、Pencol Compounding Pharmacy、McKesson Corporation、Clinigen Groupなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

カスタム配合療法市場は、種類と用途によって区分されます。世界のカスタム配合療法市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
カスタマイズ薬物、カスタマイズ食事、カスタマイズリハビリ、その他

【用途別セグメント】
病院、家庭、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- カスタム配合療法製品概要
- 種類別市場（カスタマイズ薬物、カスタマイズ食事、カスタマイズリハビリ、その他）
- 用途別市場（病院、家庭、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のカスタム配合療法販売量予測2017-2028
- 世界のカスタム配合療法売上予測2017-2028
- カスタム配合療法の地域別販売量
- カスタム配合療法の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別カスタム配合療法販売量
- 主要メーカー別カスタム配合療法売上
- 主要メーカー別カスタム配合療法価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（カスタマイズ薬物、カスタマイズ食事、カスタマイズリハビリ、その他）
- カスタム配合療法の種類別販売量
- カスタム配合療法の種類別売上
- カスタム配合療法の種類別価格
・用途別市場規模（病院、家庭、その他）
- カスタム配合療法の用途別販売量
- カスタム配合療法の用途別売上
- カスタム配合療法の用途別価格
・北米市場
- 北米のカスタム配合療法市場規模（種類別、用途別）
- 主要国別のカスタム配合療法市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのカスタム配合療法市場規模（種類別、用途別）
- 主要国別のカスタム配合療法市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のカスタム配合療法市場規模（種類別、用途別）
- 主要国別のカスタム配合療法市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のカスタム配合療法市場規模（種類別、用途別）
- 主要国別のカスタム配合療法市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのカスタム配合療法市場規模（種類別、用途別）
- 主要国別のカスタム配合療法市場規模（トルコ、サウジアラビア）
・企業情報
Fagron、Specialist Pharmacy、Nova Laboratories、Athenex Pharma Solutions、ImprimisRx、Fresenius Kabi、Baxter、B. Braun、Galenic Laboratories、Pencol Compounding Pharmacy、McKesson Corporation、Clinigen Group
・産業チェーン及び販売チャネル分析
- カスタム配合療法の産業チェーン分析
- カスタム配合療法の原材料
- カスタム配合療法の生産プロセス
- カスタム配合療法の販売及びマーケティング
- カスタム配合療法の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- カスタム配合療法の産業動向
- カスタム配合療法のマーケットドライバー
- カスタム配合療法の課題
- カスタム配合療法の阻害要因
・主な調査結果

Market Analysis and Insights: Global Custom Compounded Therapy Market
The global Custom Compounded Therapy market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Drug Customization accounting for % of the Custom Compounded Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Custom Compounded Therapy market size is valued at US$ million in 2021, while the North America and Europe Custom Compounded Therapy are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Custom Compounded Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Custom Compounded Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Custom Compounded Therapy market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Custom Compounded Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Custom Compounded Therapy market.
Global Custom Compounded Therapy Scope and Market Size
Custom Compounded Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Custom Compounded Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Drug Customization
Meal Customization
Rehabilitation Customization
Other
Segment by Application
Hospital
Family
Other
By Company
Fagron
Specialist Pharmacy
Nova Laboratories
Athenex Pharma Solutions
ImprimisRx
Fresenius Kabi
Baxter
B. Braun
Galenic Laboratories
Pencol Compounding Pharmacy
McKesson Corporation
Clinigen Group
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Custom Compounded Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Drug Customization
1.2.3 Meal Customization
1.2.4 Rehabilitation Customization
1.2.5 Other
1.3 Market by Application
1.3.1 Global Custom Compounded Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Family
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Custom Compounded Therapy Market Perspective (2017-2028)
2.2 Custom Compounded Therapy Growth Trends by Region
2.2.1 Custom Compounded Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Custom Compounded Therapy Historic Market Size by Region (2017-2022)
2.2.3 Custom Compounded Therapy Forecasted Market Size by Region (2023-2028)
2.3 Custom Compounded Therapy Market Dynamics
2.3.1 Custom Compounded Therapy Industry Trends
2.3.2 Custom Compounded Therapy Market Drivers
2.3.3 Custom Compounded Therapy Market Challenges
2.3.4 Custom Compounded Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Custom Compounded Therapy Players by Revenue
3.1.1 Global Top Custom Compounded Therapy Players by Revenue (2017-2022)
3.1.2 Global Custom Compounded Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Custom Compounded Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Custom Compounded Therapy Revenue
3.4 Global Custom Compounded Therapy Market Concentration Ratio
3.4.1 Global Custom Compounded Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Custom Compounded Therapy Revenue in 2021
3.5 Custom Compounded Therapy Key Players Head office and Area Served
3.6 Key Players Custom Compounded Therapy Product Solution and Service
3.7 Date of Enter into Custom Compounded Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Custom Compounded Therapy Breakdown Data by Type
4.1 Global Custom Compounded Therapy Historic Market Size by Type (2017-2022)
4.2 Global Custom Compounded Therapy Forecasted Market Size by Type (2023-2028)
5 Custom Compounded Therapy Breakdown Data by Application
5.1 Global Custom Compounded Therapy Historic Market Size by Application (2017-2022)
5.2 Global Custom Compounded Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Custom Compounded Therapy Market Size (2017-2028)
6.2 North America Custom Compounded Therapy Market Size by Type
6.2.1 North America Custom Compounded Therapy Market Size by Type (2017-2022)
6.2.2 North America Custom Compounded Therapy Market Size by Type (2023-2028)
6.2.3 North America Custom Compounded Therapy Market Share by Type (2017-2028)
6.3 North America Custom Compounded Therapy Market Size by Application
6.3.1 North America Custom Compounded Therapy Market Size by Application (2017-2022)
6.3.2 North America Custom Compounded Therapy Market Size by Application (2023-2028)
6.3.3 North America Custom Compounded Therapy Market Share by Application (2017-2028)
6.4 North America Custom Compounded Therapy Market Size by Country
6.4.1 North America Custom Compounded Therapy Market Size by Country (2017-2022)
6.4.2 North America Custom Compounded Therapy Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Custom Compounded Therapy Market Size (2017-2028)
7.2 Europe Custom Compounded Therapy Market Size by Type
7.2.1 Europe Custom Compounded Therapy Market Size by Type (2017-2022)
7.2.2 Europe Custom Compounded Therapy Market Size by Type (2023-2028)
7.2.3 Europe Custom Compounded Therapy Market Share by Type (2017-2028)
7.3 Europe Custom Compounded Therapy Market Size by Application
7.3.1 Europe Custom Compounded Therapy Market Size by Application (2017-2022)
7.3.2 Europe Custom Compounded Therapy Market Size by Application (2023-2028)
7.3.3 Europe Custom Compounded Therapy Market Share by Application (2017-2028)
7.4 Europe Custom Compounded Therapy Market Size by Country
7.4.1 Europe Custom Compounded Therapy Market Size by Country (2017-2022)
7.4.2 Europe Custom Compounded Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Custom Compounded Therapy Market Size (2017-2028)
8.2 Asia-Pacific Custom Compounded Therapy Market Size by Type
8.2.1 Asia-Pacific Custom Compounded Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Custom Compounded Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Custom Compounded Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Custom Compounded Therapy Market Size by Application
8.3.1 Asia-Pacific Custom Compounded Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Custom Compounded Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Custom Compounded Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Custom Compounded Therapy Market Size by Region
8.4.1 Asia-Pacific Custom Compounded Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Custom Compounded Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Custom Compounded Therapy Market Size (2017-2028)
9.2 Latin America Custom Compounded Therapy Market Size by Type
9.2.1 Latin America Custom Compounded Therapy Market Size by Type (2017-2022)
9.2.2 Latin America Custom Compounded Therapy Market Size by Type (2023-2028)
9.2.3 Latin America Custom Compounded Therapy Market Share by Type (2017-2028)
9.3 Latin America Custom Compounded Therapy Market Size by Application
9.3.1 Latin America Custom Compounded Therapy Market Size by Application (2017-2022)
9.3.2 Latin America Custom Compounded Therapy Market Size by Application (2023-2028)
9.3.3 Latin America Custom Compounded Therapy Market Share by Application (2017-2028)
9.4 Latin America Custom Compounded Therapy Market Size by Country
9.4.1 Latin America Custom Compounded Therapy Market Size by Country (2017-2022)
9.4.2 Latin America Custom Compounded Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Custom Compounded Therapy Market Size (2017-2028)
10.2 Middle East & Africa Custom Compounded Therapy Market Size by Type
10.2.1 Middle East & Africa Custom Compounded Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Custom Compounded Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Custom Compounded Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Custom Compounded Therapy Market Size by Application
10.3.1 Middle East & Africa Custom Compounded Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Custom Compounded Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Custom Compounded Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Custom Compounded Therapy Market Size by Country
10.4.1 Middle East & Africa Custom Compounded Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Custom Compounded Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Fagron
11.1.1 Fagron Company Details
11.1.2 Fagron Business Overview
11.1.3 Fagron Custom Compounded Therapy Introduction
11.1.4 Fagron Revenue in Custom Compounded Therapy Business (2017-2022)
11.1.5 Fagron Recent Developments
11.2 Specialist Pharmacy
11.2.1 Specialist Pharmacy Company Details
11.2.2 Specialist Pharmacy Business Overview
11.2.3 Specialist Pharmacy Custom Compounded Therapy Introduction
11.2.4 Specialist Pharmacy Revenue in Custom Compounded Therapy Business (2017-2022)
11.2.5 Specialist Pharmacy Recent Developments
11.3 Nova Laboratories
11.3.1 Nova Laboratories Company Details
11.3.2 Nova Laboratories Business Overview
11.3.3 Nova Laboratories Custom Compounded Therapy Introduction
11.3.4 Nova Laboratories Revenue in Custom Compounded Therapy Business (2017-2022)
11.3.5 Nova Laboratories Recent Developments
11.4 Athenex Pharma Solutions
11.4.1 Athenex Pharma Solutions Company Details
11.4.2 Athenex Pharma Solutions Business Overview
11.4.3 Athenex Pharma Solutions Custom Compounded Therapy Introduction
11.4.4 Athenex Pharma Solutions Revenue in Custom Compounded Therapy Business (2017-2022)
11.4.5 Athenex Pharma Solutions Recent Developments
11.5 ImprimisRx
11.5.1 ImprimisRx Company Details
11.5.2 ImprimisRx Business Overview
11.5.3 ImprimisRx Custom Compounded Therapy Introduction
11.5.4 ImprimisRx Revenue in Custom Compounded Therapy Business (2017-2022)
11.5.5 ImprimisRx Recent Developments
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Details
11.6.2 Fresenius Kabi Business Overview
11.6.3 Fresenius Kabi Custom Compounded Therapy Introduction
11.6.4 Fresenius Kabi Revenue in Custom Compounded Therapy Business (2017-2022)
11.6.5 Fresenius Kabi Recent Developments
11.7 Baxter
11.7.1 Baxter Company Details
11.7.2 Baxter Business Overview
11.7.3 Baxter Custom Compounded Therapy Introduction
11.7.4 Baxter Revenue in Custom Compounded Therapy Business (2017-2022)
11.7.5 Baxter Recent Developments
11.8 B. Braun
11.8.1 B. Braun Company Details
11.8.2 B. Braun Business Overview
11.8.3 B. Braun Custom Compounded Therapy Introduction
11.8.4 B. Braun Revenue in Custom Compounded Therapy Business (2017-2022)
11.8.5 B. Braun Recent Developments
11.9 Galenic Laboratories
11.9.1 Galenic Laboratories Company Details
11.9.2 Galenic Laboratories Business Overview
11.9.3 Galenic Laboratories Custom Compounded Therapy Introduction
11.9.4 Galenic Laboratories Revenue in Custom Compounded Therapy Business (2017-2022)
11.9.5 Galenic Laboratories Recent Developments
11.10 Pencol Compounding Pharmacy
11.10.1 Pencol Compounding Pharmacy Company Details
11.10.2 Pencol Compounding Pharmacy Business Overview
11.10.3 Pencol Compounding Pharmacy Custom Compounded Therapy Introduction
11.10.4 Pencol Compounding Pharmacy Revenue in Custom Compounded Therapy Business (2017-2022)
11.10.5 Pencol Compounding Pharmacy Recent Developments
11.11 McKesson Corporation
11.11.1 McKesson Corporation Company Details
11.11.2 McKesson Corporation Business Overview
11.11.3 McKesson Corporation Custom Compounded Therapy Introduction
11.11.4 McKesson Corporation Revenue in Custom Compounded Therapy Business (2017-2022)
11.11.5 McKesson Corporation Recent Developments
11.12 Clinigen Group
11.12.1 Clinigen Group Company Details
11.12.2 Clinigen Group Business Overview
11.12.3 Clinigen Group Custom Compounded Therapy Introduction
11.12.4 Clinigen Group Revenue in Custom Compounded Therapy Business (2017-2022)
11.12.5 Clinigen Group Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Custom Compounded Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Drug Customization
Table 3. Key Players of Meal Customization
Table 4. Key Players of Rehabilitation Customization
Table 5. Key Players of Other
Table 6. Global Custom Compounded Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Custom Compounded Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Custom Compounded Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Custom Compounded Therapy Market Share by Region (2017-2022)
Table 10. Global Custom Compounded Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Custom Compounded Therapy Market Share by Region (2023-2028)
Table 12. Custom Compounded Therapy Market Trends
Table 13. Custom Compounded Therapy Market Drivers
Table 14. Custom Compounded Therapy Market Challenges
Table 15. Custom Compounded Therapy Market Restraints
Table 16. Global Custom Compounded Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Custom Compounded Therapy Revenue Share by Players (2017-2022)
Table 18. Global Top Custom Compounded Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Custom Compounded Therapy as of 2021)
Table 19. Ranking of Global Top Custom Compounded Therapy Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Custom Compounded Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Custom Compounded Therapy Product Solution and Service
Table 23. Date of Enter into Custom Compounded Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Custom Compounded Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Custom Compounded Therapy Revenue Market Share by Type (2017-2022)
Table 27. Global Custom Compounded Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Custom Compounded Therapy Revenue Market Share by Type (2023-2028)
Table 29. Global Custom Compounded Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Custom Compounded Therapy Revenue Share by Application (2017-2022)
Table 31. Global Custom Compounded Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Custom Compounded Therapy Revenue Share by Application (2023-2028)
Table 33. North America Custom Compounded Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Custom Compounded Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Custom Compounded Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Custom Compounded Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Custom Compounded Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Custom Compounded Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Custom Compounded Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Custom Compounded Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Custom Compounded Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Custom Compounded Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Custom Compounded Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Custom Compounded Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Custom Compounded Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Custom Compounded Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Custom Compounded Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Custom Compounded Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Custom Compounded Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Custom Compounded Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Custom Compounded Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Custom Compounded Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Custom Compounded Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Custom Compounded Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Custom Compounded Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Custom Compounded Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Custom Compounded Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Custom Compounded Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Custom Compounded Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Custom Compounded Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Custom Compounded Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Custom Compounded Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 63. Fagron Company Details
Table 64. Fagron Business Overview
Table 65. Fagron Custom Compounded Therapy Product
Table 66. Fagron Revenue in Custom Compounded Therapy Business (2017-2022) & (US$ Million)
Table 67. Fagron Recent Developments
Table 68. Specialist Pharmacy Company Details
Table 69. Specialist Pharmacy Business Overview
Table 70. Specialist Pharmacy Custom Compounded Therapy Product
Table 71. Specialist Pharmacy Revenue in Custom Compounded Therapy Business (2017-2022) & (US$ Million)
Table 72. Specialist Pharmacy Recent Developments
Table 73. Nova Laboratories Company Details
Table 74. Nova Laboratories Business Overview
Table 75. Nova Laboratories Custom Compounded Therapy Product
Table 76. Nova Laboratories Revenue in Custom Compounded Therapy Business (2017-2022) & (US$ Million)
Table 77. Nova Laboratories Recent Developments
Table 78. Athenex Pharma Solutions Company Details
Table 79. Athenex Pharma Solutions Business Overview
Table 80. Athenex Pharma Solutions Custom Compounded Therapy Product
Table 81. Athenex Pharma Solutions Revenue in Custom Compounded Therapy Business (2017-2022) & (US$ Million)
Table 82. Athenex Pharma Solutions Recent Developments
Table 83. ImprimisRx Company Details
Table 84. ImprimisRx Business Overview
Table 85. ImprimisRx Custom Compounded Therapy Product
Table 86. ImprimisRx Revenue in Custom Compounded Therapy Business (2017-2022) & (US$ Million)
Table 87. ImprimisRx Recent Developments
Table 88. Fresenius Kabi Company Details
Table 89. Fresenius Kabi Business Overview
Table 90. Fresenius Kabi Custom Compounded Therapy Product
Table 91. Fresenius Kabi Revenue in Custom Compounded Therapy Business (2017-2022) & (US$ Million)
Table 92. Fresenius Kabi Recent Developments
Table 93. Baxter Company Details
Table 94. Baxter Business Overview
Table 95. Baxter Custom Compounded Therapy Product
Table 96. Baxter Revenue in Custom Compounded Therapy Business (2017-2022) & (US$ Million)
Table 97. Baxter Recent Developments
Table 98. B. Braun Company Details
Table 99. B. Braun Business Overview
Table 100. B. Braun Custom Compounded Therapy Product
Table 101. B. Braun Revenue in Custom Compounded Therapy Business (2017-2022) & (US$ Million)
Table 102. B. Braun Recent Developments
Table 103. Galenic Laboratories Company Details
Table 104. Galenic Laboratories Business Overview
Table 105. Galenic Laboratories Custom Compounded Therapy Product
Table 106. Galenic Laboratories Revenue in Custom Compounded Therapy Business (2017-2022) & (US$ Million)
Table 107. Galenic Laboratories Recent Developments
Table 108. Pencol Compounding Pharmacy Company Details
Table 109. Pencol Compounding Pharmacy Business Overview
Table 110. Pencol Compounding Pharmacy Custom Compounded Therapy Product
Table 111. Pencol Compounding Pharmacy Revenue in Custom Compounded Therapy Business (2017-2022) & (US$ Million)
Table 112. Pencol Compounding Pharmacy Recent Developments
Table 113. McKesson Corporation Company Details
Table 114. McKesson Corporation Business Overview
Table 115. McKesson Corporation Custom Compounded Therapy Product
Table 116. McKesson Corporation Revenue in Custom Compounded Therapy Business (2017-2022) & (US$ Million)
Table 117. McKesson Corporation Recent Developments
Table 118. Clinigen Group Company Details
Table 119. Clinigen Group Business Overview
Table 120. Clinigen Group Custom Compounded Therapy Product
Table 121. Clinigen Group Revenue in Custom Compounded Therapy Business (2017-2022) & (US$ Million)
Table 122. Clinigen Group Recent Developments
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Custom Compounded Therapy Market Share by Type: 2021 VS 2028
Figure 2. Drug Customization Features
Figure 3. Meal Customization Features
Figure 4. Rehabilitation Customization Features
Figure 5. Other Features
Figure 6. Global Custom Compounded Therapy Market Share by Application: 2021 VS 2028
Figure 7. Hospital Case Studies
Figure 8. Family Case Studies
Figure 9. Other Case Studies
Figure 10. Custom Compounded Therapy Report Years Considered
Figure 11. Global Custom Compounded Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Custom Compounded Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Custom Compounded Therapy Market Share by Region: 2021 VS 2028
Figure 14. Global Custom Compounded Therapy Market Share by Players in 2021
Figure 15. Global Top Custom Compounded Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Custom Compounded Therapy as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Custom Compounded Therapy Revenue in 2021
Figure 17. North America Custom Compounded Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Custom Compounded Therapy Market Size Market Share by Type (2017-2028)
Figure 19. North America Custom Compounded Therapy Market Size Market Share by Application (2017-2028)
Figure 20. North America Custom Compounded Therapy Market Size Share by Country (2017-2028)
Figure 21. United States Custom Compounded Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Custom Compounded Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Custom Compounded Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Custom Compounded Therapy Market Size Market Share by Type (2017-2028)
Figure 25. Europe Custom Compounded Therapy Market Size Market Share by Application (2017-2028)
Figure 26. Europe Custom Compounded Therapy Market Size Share by Country (2017-2028)
Figure 27. Germany Custom Compounded Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Custom Compounded Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Custom Compounded Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Custom Compounded Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Custom Compounded Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Custom Compounded Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Custom Compounded Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Custom Compounded Therapy Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Custom Compounded Therapy Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Custom Compounded Therapy Market Size Share by Region (2017-2028)
Figure 37. China Custom Compounded Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Custom Compounded Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Custom Compounded Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Custom Compounded Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Custom Compounded Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Custom Compounded Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Custom Compounded Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Custom Compounded Therapy Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Custom Compounded Therapy Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Custom Compounded Therapy Market Size Share by Country (2017-2028)
Figure 47. Mexico Custom Compounded Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Custom Compounded Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Custom Compounded Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Custom Compounded Therapy Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Custom Compounded Therapy Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Custom Compounded Therapy Market Size Share by Country (2017-2028)
Figure 53. Turkey Custom Compounded Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Custom Compounded Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Custom Compounded Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Fagron Revenue Growth Rate in Custom Compounded Therapy Business (2017-2022)
Figure 57. Specialist Pharmacy Revenue Growth Rate in Custom Compounded Therapy Business (2017-2022)
Figure 58. Nova Laboratories Revenue Growth Rate in Custom Compounded Therapy Business (2017-2022)
Figure 59. Athenex Pharma Solutions Revenue Growth Rate in Custom Compounded Therapy Business (2017-2022)
Figure 60. ImprimisRx Revenue Growth Rate in Custom Compounded Therapy Business (2017-2022)
Figure 61. Fresenius Kabi Revenue Growth Rate in Custom Compounded Therapy Business (2017-2022)
Figure 62. Baxter Revenue Growth Rate in Custom Compounded Therapy Business (2017-2022)
Figure 63. B. Braun Revenue Growth Rate in Custom Compounded Therapy Business (2017-2022)
Figure 64. Galenic Laboratories Revenue Growth Rate in Custom Compounded Therapy Business (2017-2022)
Figure 65. Pencol Compounding Pharmacy Revenue Growth Rate in Custom Compounded Therapy Business (2017-2022)
Figure 66. McKesson Corporation Revenue Growth Rate in Custom Compounded Therapy Business (2017-2022)
Figure 67. Clinigen Group Revenue Growth Rate in Custom Compounded Therapy Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

配合滅菌製剤薬局のグローバル市場インサイト・予測（～2028年）

Global Compounded Sterile Preparations Pharmacy Market Insights, Forecast to 2028
QY2207C3478 2022年7月11日 98Pages
新型コロナウイルス感染症のパンデミックにより、世界の配合滅菌製剤薬局の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に配合滅菌製剤薬局の世...

がん光線力学療法のグローバル市場インサイト・予測（～2028年）

Global Cancer Photodynamic Therapy Market Insights, Forecast to 2028
QY2207C3467 2022年7月11日 109Pages
新型コロナウイルス感染症のパンデミックにより、世界のがん光線力学療法の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にがん光線力学療法の世...

エクソソーム療法のグローバル市場インサイト・予測（～2028年）

Global Exosome Therapy Market Insights, Forecast to 2028
QY2207C3823 2022年7月11日 108Pages
新型コロナウイルス感染症のパンデミックにより、世界のエクソソーム療法の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にエクソソーム療法の世...

末期腎疾患（ESRD）療法のグローバル市場インサイト・予測（～2028年）

Global End Stage Renal Disease (ESRD) Therapy Market Insights, Forecast to 2028
QY2207C3545 2022年7月11日 110Pages
新型コロナウイルス感染症のパンデミックにより、世界の末期腎疾患（ESRD）療法の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に末期腎疾患...

細胞治療用アイソレーターのグローバル市場インサイト・予測（～2028年）

Global Cell Therapy Isolators Market Insights, Forecast to 2028
QY2207C3672 2022年7月11日 106Pages
新型コロナウイルス感染症のパンデミックにより、世界の細胞治療用アイソレーターの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に細胞治療用ア...

配合滅菌製剤薬局のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Compounded Sterile Preparations Pharmacy Market The global Compounded Sterile Preparations Pharmacy market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this hea…
がん光線力学療法のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Cancer Photodynamic Therapy Market The global Cancer Photodynamic Therapy market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health crisis, Device account…
エクソソーム療法のグローバル市場インサイト・予測（～2028年） Exosome technology can directly release specific miRNAs into tumor cells for the treatment of cholangiocarcinoma. Market Analysis and Insights: Global Exosome Therapy Market The global Exosome Therapy market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % dur…
カスタムロールフォーミングサービスのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Custom Roll Forming Services Market The global Custom Roll Forming Services market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health crisis, Cold Roll Fo…
末期腎疾患（ESRD）療法のグローバル市場インサイト・予測（～2028年） End-stage renal failure, also known as end-stage renal disease (ESRD), is can be caused by an underlying health problem, often diabetes or high blood pressure. ESRD is the final, permanent stage of chronic kidney disease, where kidney function has declined to the point that the kidneys can no longer…